인투인월드

NexBridge Bio connects pharmaceutical companies with Korean contract research organizations (CROs), helping sponsors explore and coordinate clinical trial projects in Korea. Its services cover pharmaceutical and medical device clinical trials, including quotation requests and discussions to clarify project requirements. The company emphasizes practical planning, transparent costs, and responsive communication throughout project coordination.

Drawing on more than 10 years of experience in Korea’s clinical trial industry, NexBridge Bio reports a network of more than 50 partner sites, including major tertiary hospitals and other leading institutions. It also highlights therapeutic-area expertise in fields such as oncology and hematology. Its approach includes quantitative assessment of timelines and risks, clear budget breakdowns, and prompt updates when project details change. The company reports 100% compliance with project milestone timelines over the past five years, alongside a high rate of repeat business. NexBridge Bio also shares industry insights, regulatory updates, global submission information, clinical trends, CRO knowledge, and Korean trial statistics through its website and newsletter.